Central Nervous System International Prognostic Index (CNS-IPI)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–1
- Intermediate Risk2–3
- High Risk4–6
The Central Nervous System International Prognostic Index (CNS-IPI) calculator is designed for bedside predicting the risk of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP chemotherapy in clinical practice. The resulting score directly guides clinician decision-making regarding.
Clinical Guidelines & Evidence
Prognostic scoring system that predicts the risk of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP chemotherapy. Helps identify patients who may benefit from CNS-directed prophylaxis and guides treatment planning decisions.
Clinical Indication
The Central Nervous System International Prognostic Index (CNS-IPI) is indicated for bedside clinical practice to support Prognostic scoring system that predicts the risk of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP chemotherapy. Helps identify patients who may benefit from CNS-directed prophylaxis and guides treatment planning decisions.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.
Limitations & Contraindications
Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.
Clinical Pearls & Action Plan
Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies. Guideline pearl: Score should be calculated at initial diagnosis before treatment initiation.
CNS-IPI Score = Age >60 years (1) + LDH >normal (1) + ECOG PS >1 (1) + Ann Arbor stage III/IV (1) + >1 extranodal site (1) + Kidney/adrenal involvement (1). Total range: 0-6 points.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_over_60 | string | Yes | Patient age greater than 60 years |
| elevated_ldh | string | Yes | Lactate dehydrogenase (LDH) level above normal laboratory range |
| ecog_performance_status_over_1 | string | Yes | ECOG Performance Status greater than 1 (moderate to severe limitation of activity) |
| advanced_stage | string | Yes | Ann Arbor stage III or IV disease (advanced stage) |
| multiple_extranodal_sites | string | Yes | More than 1 extranodal disease site involved |
| kidney_adrenal_involvement | string | Yes | Involvement of kidney and/or adrenal gland |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1 | Low Risk | Very low CNS relapse risk |
| 2–3 | Intermediate Risk | Low to moderate CNS relapse risk |
| 4–6 | High Risk | High CNS relapse risk |
Evidence-Based References (EBM)
- Schmitz N, Zeynalova S, Nickelsen M, Kansara R, Villa D, Sehn LH, et al. CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP. J Clin Oncol. 2016 Sep 10;34(26):3150-3156. doi: 10.1200/JCO.2015.65.6520.DOI: 10.1200/JCO.2015.65.6520
- Ma'koseh M, Rahahleh N, Abdel-Razeq H. Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma. Cureus. 2021 Aug 13;13(8):e17016. doi: 10.7759/cureus.17016.DOI: 10.7759/cureus.17016
- Savage KJ, Slack GW, Mottok A, Sehn LH, Villa D, Kansara R, et al. Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL. Blood. 2016 Apr 28;127(17):2182-8. doi: 10.1182/blood-2015-10-676700.DOI: 10.1182/blood-2015-10-676700
Related calculators
- International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI)
- International Prognostic Index for Diffuse Large B-cell Lymphoma (IPI and R-IPI)
- National Comprehensive Cancer Network International Prognostic Index (NCCN-IPI)
- Follicular Lymphoma International Prognostic Index (FLIPI)
- Mantle Cell Lymphoma International Prognostic Index (MIPI)